Seattle Genetics Inc. (SGEN) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q2 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $48.8 million versus the consensus estimate of $50.33 million.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- Evaxion adds brain cancer vaccine program, drops EVX-03
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
